ResMed Inc. (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed Inc. (ASX: RMD)
Latest News
Growth Shares
10 quality ASX shares to buy for 2020
⏸️ ASX Shares
Where to invest $1,000 into ASX shares in 2020
Share Market News
5 things to watch on the ASX 200 on Thursday
⏸️ ASX Shares
Why I would buy these top ASX 200 blue chip shares in 2020
Growth Shares
10 ASX large caps to buy for 2020
Share Market News
Why the Medical Developments share price is up 50% since October
Share Market News
Would an investment in ResMed shares help you sleep better?
Record Highs
Why ResMed and these ASX 200 shares just hit all-time highs
⏸️ ASX Shares
Are these the best blue chip shares to buy on the ASX 200?
Share Market News
Goldman Sachs on the fence over Sonic shares
Share Market News
Goldman Sachs tips Fisher & Paykel shares as a sell
Share Market News
Goldman Sachs tips Ramsay shares as a sell
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.
